Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DOL04T
|
|||
| Drug Name |
CPCB-RPE1
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Dry age-related macular degeneration [ICD-11: 9B75; ICD-10: H35.31] | Phase 1/2 | [1] | |
| Company |
Regenerative Patch Technologies
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02590692) Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.